Document is current
Any future updates will be listed below
-
Authors
Wang, Haowei
Xiong, Anwen
Chen, Xiaoxia
Guo, Junhong
Tang, Zhuoran
Wu, Chunyan
Ren, Shengxiang
Zhou, Caicun https://orcid.org/0000-0002-1072-9941
Chen, Jian
Hou, Likun
Jiang, Tao https://orcid.org/0000-0002-9205-8183
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82102859)
Shanghai Science and Technology Development Foundation (No. 23Y11904100)
- License Information
-
More Information
Article History
Received: 18 May 2024
Revised: 16 October 2024
Accepted: 31 October 2024
First Online: 6 December 2024
Competing interests
: Caicun Zhou has disclosed receiving speaker honoraria from Roche, Lily China, Boehringer Ingelheim, Merck, Hengrui, Qilu and Amoy Diagnostics. Additionally, Zhou has received advisory fees from Innovent Biologics, Hengrui, Qilu. Shengxiang Ren has reported receiving speaker honoraria from Boehringer Ingelheim, Lilly, and advisory fees from Roche and Boehringer Ingelheim. Ren has also received research funding from Hengrui. No further disclosures were reported.
